Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging

Insights into Imaging

卷:9

for the European Society of Breast Imaging (EUSOBI) , with language review by Europa Donna–The European Breast Cancer Coalition¹  Alexandra Athanasiou²  Pietro Panizza³  Eva M. Fallenberg⁴  Ulrich Bick⁴  Katja Pinker⁵  Thomas H. Helbich⁵  Paola Clauser⁵  Pascal A. Baltzer⁵  Francesco Sardanelli⁶  Ruud M. Pijnappel⁷  Federica Pediconi⁸  Gabor Forrai⁹  Corinne Balleyguier¹⁰  Ritse M. Mann¹¹  Julia Camps Herrero¹²  Fiona J. Gilbert¹³  Sophia Zackrisson¹⁴  Michael H. Fuchsjaeger¹⁵  Andrew Evans¹⁶  Karen Kinkel¹⁷  Rubina M. Trimboli¹⁸  Catherine Colin¹⁹  Sylvia H. Heywang-Köbrunner²⁰  Eleanor Cornford²¹  Laura Martincich²²  Christiane K. Kuhl²³ 

[1] ;

[2] Breast Imaging Department, MITERA Hospital;

[3] Breast Imaging Unit, Scientific Institute (IRCCS) Ospedale San Raffaele;

[4] Clinic of Radiology, Charité Universitätsmedizin Berlin;

[5] Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna;

[6] Department of Biomedical Sciences for Health, Università degli Studi di Milano;

[7] Department of Imaging, University Medical Centre Utrecht;

[8] Department of Radiological, Oncological and Pathological Sciences, Sapienza University;

[9] Department of Radiology, Duna Medical Center;

[10] Department of Radiology, Gustave-Roussy Cancer Campus;

[11] Department of Radiology, Radboud University Nijmegen Medical Centre;

[12] Department of Radiology, University Hospital of La Ribera;

[13] Department of Radiology, University of Cambridge;

[14] Diagnostic Radiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Skåne University Hospital Malmö;

[15] Division of General Radiology, Department of Radiology, Medical University Graz;

[16] Dundee Cancer Centre, Clinical Research Centre, Ninewells Hospital and Medical School;

[17] Institut de Radiologie, Clinique des Grangettes;

[18] PhD Course in Integrative Biomedical Research, Department of Biomedical Science for Health, Università degli Studi di Milano;

[19] Radiology Unit, Hospices Civils de Lyon, Centre Hospitalo-Universitaire Femme Mère Enfant;

[20] Referenzzentrum Mammographie München and FFB gGmbH München;

[21] Thirlestaine Breast Centre, Cheltenham General Hospital;

[22] Unità Operativa Radiodiagnostica, Candiolo Cancer Institute - FPO, IRCCS;

[23] University Hospital of Aachen, Rheinisch-Westfälische Technische Hochschule;

关键词: Breast cancer;    Breast ultrasound (US);    BI-RADS;    Colour-Doppler;    Elastography;    Automated whole breast ultrasound;   

DOI  :  10.1007/s13244-018-0636-z

来源: DOAJ

【 摘 要 】

Abstract This article summarises the information that should be provided to women and referring physicians about breast ultrasound (US). After explaining the physical principles, technical procedure and safety of US, information is given about its ability to make a correct diagnosis, depending on the setting in which it is applied. The following definite indications for breast US in female subjects are proposed: palpable lump; axillary adenopathy; first diagnostic approach for clinical abnormalities under 40 and in pregnant or lactating women; suspicious abnormalities at mammography or magnetic resonance imaging (MRI); suspicious nipple discharge; recent nipple inversion; skin retraction; breast inflammation; abnormalities in the area of the surgical scar after breast conserving surgery or mastectomy; abnormalities in the presence of breast implants; screening high-risk women, especially when MRI is not performed; loco-regional staging of a known breast cancer, when MRI is not performed; guidance for percutaneous interventions (needle biopsy, pre-surgical localisation, fluid collection drainage); monitoring patients with breast cancer receiving neo-adjuvant therapy, when MRI is not performed. Possible indications such as supplemental screening after mammography for women aged 40–74 with dense breasts are also listed. Moreover, inappropriate indications include screening for breast cancer as a stand-alone alternative to mammography. The structure and organisation of the breast US report and of classification systems such as the BI-RADS and consequent management recommendations are illustrated. Information about additional or new US technologies (colour-Doppler, elastography, and automated whole breast US) is also provided. Finally, five frequently asked questions are answered. Teaching Points • US is an established tool for suspected cancers at all ages and also the method of choice under 40. • For US-visible suspicious lesions, US-guided biopsy is preferred, even for palpable findings. • High-risk women can be screened with US, especially when MRI cannot be performed. • Supplemental US increases cancer detection but also false positives, biopsy rate and follow-up exams. • Breast US is inappropriate as a stand-alone screening method.

【 授权许可】

Unknown